drugset / Trial / NCT03646058
Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode
RandomizedParallel-groupDouble-blindTreatment
Summary
This study aims at investigating if adjunctive buprenorphine at low dose to treatment as usual is effective in reducing severe suicidal ideas in major depressive episode, and at determining the most effective dose.
Timeline
- Start
- 2021-10-10
- Primary completion
- 2026-10
- Completion
- 2027-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | 0.4 mg | Other |
| Subject | Buprenorphine | Other / unclassified | 0.8 mg | Other |